1. Anti-inflammatory potentials of incretin-based therapies used in the management of diabetes
   Habib Yaribeygi et al, 2020, Life Sciences CrossRef
2. Differential effects of RYGB surgery and best medical treatment for obesity-diabetes on intestinal and islet adaptations in obese-diabetic ZDSD rats
   Ananyaa Sridhar et al, 2022, PLOS ONE CrossRef
3. GLP-2 Is Locally Produced From Human Islets and Balances Inflammation Through an Inter-Islet-Immune Cell Crosstalk
   Wei He et al, 2021, Frontiers in Endocrinology CrossRef
4. Preventive treatment with liraglutide protects against development of glucose intolerance in a rat model of Wolfram syndrome
   Maarja Toots et al, 2018, Scientific Reports CrossRef
5. Anti-Inflammatory Strategies Targeting Metaflammation in Type 2 Diabetes
   Alina Kuryłowicz et al, 2020, Molecules CrossRef
6. The Role of GLP1-RAs in Direct Modulation of Lipid Metabolism in Hepatic Tissue as Determined Using In Vitro Models of NAFLD
   Ana Petrovic et al, 2023, Current Issues in Molecular Biology CrossRef
7. Exenatide, Metformin, or Both for Prediabetes in PCOS: A Randomized, Open-label, Parallel-group Controlled Study
   Tao Tao et al, 2021, The Journal of Clinical Endocrinology & Metabolism CrossRef
8. Berberine Reshapes the Balance of the Local Renin-Angiotensin System by Modulating Autophagy under Metabolic Stress in Pancreatic Islets
   Chenghu Huang et al, 2021, Journal of the Renin-Angiotensin-Aldosterone System CrossRef
9. Antidiabetic Drugs and their Potential Use in COVID-19: A Mechanistic Approach
   Isaias Balderas-Renteria et al, 2023, Endocrine, Metabolic & Immune Disorders - Drug Targets CrossRef
10. Characteristics and molecular mechanisms through which SGLT2 inhibitors improve metabolic diseases: A mechanism review
    Xie Lingli et al, 2022, Life Sciences CrossRef
11. Gene Expression Modifications in Type 2 Diabetes
    Fernando Suarez-Sanchez et al, 2019, The Diabetes Textbook CrossRef
12. Gene Expression Modifications in Type 2 Diabetes
    Fernando Suárez-Sánchez et al, 2023, The Diabetes Textbook CrossRef
13. The Effects and Treatment of Inflammation on Diabetes Mellitus and Cardiovascular Disease
    Laith Hattar et al, 2023, Diabetes and Cardiovascular Disease CrossRef
14. Crosstalk between incretin hormones, Th17 and Treg cells in inflammatory diseases
    Eloisa Martins da Silva et al, 2022, Peptides CrossRef
15. Mechanisms of Action of Liraglutide in Patients With Type 2 Diabetes Treated With High-Dose Insulin
    Anna Vanderheiden et al, 2016, The Journal of Clinical Endocrinology & Metabolism CrossRef
16. Chronic exposure to incretin metabolites GLP-1(9−36) and GIP(3−42) affect islet morphology and beta cell health in high fat fed mice
    Ananyaa Sridhar et al, 2024, Peptides CrossRef
17. Fourteen composite probiotics alleviate type 2 diabetes through modulating gut microbiota and modifying M1/M2 phenotype macrophage in db/db mice
    Yanming Wang et al, 2020, Pharmacological Research CrossRef
18. Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control
    Young-Sun Lee et al, 2016, Mediators of Inflammation CrossRef
19. The role of incretins and incretin-based drugs in autoimmune diseases
    Shabnam Radbakhsh et al, 2021, International Immunopharmacology CrossRef
20. Differential effects of angiotensin receptor blockers on pancreatic islet remodelling and glucose homeostasis in diet-induced obese mice
    Francielle Graus-Nunes et al, 2017, Molecular and Cellular Endocrinology CrossRef
21. The Impact of Incretin-Based Medications on Lipid Metabolism
    Habib Yaribeygi et al, 2021, Journal of Diabetes Research CrossRef
22. Development of Syringaldehyde as an Agonist of the GLP-1 Receptor to Alleviate Diabetic Disorders in Animal Models
    Jenpei Lee et al, 2024, Pharmaceuticals CrossRef
23. Intra-islet glucagon-like peptide 1
    Genevieve E. Fava et al, 2016, Journal of Diabetes and its Complications CrossRef
24. G Protein–Coupled Receptors Targeting Insulin Resistance, Obesity, and Type 2 Diabetes Mellitus
    Darren M. Riddy et al, 2018, Pharmacological Reviews CrossRef
25. Early protein restriction increases intra-islet GLP-1 production and pancreatic β-cell proliferation mediated by the β-catenin pathway
    Chaiane Aline da Rosa-Santos et al, 2020, European Journal of Nutrition CrossRef
26. A GLP‑1 receptor agonist attenuates human islet amyloid polypeptide‑induced autophagy and apoptosis in MIN6 cells
    Xiong Chen et al, 2018, Molecular Medicine Reports CrossRef
27. Mechanisms of Beta-Cell Apoptosis in Type 2 Diabetes-Prone Situations and Potential Protection by GLP-1-Based Therapies
    Safia Costes et al, 2021, International Journal of Molecular Sciences CrossRef
28. Activation of ACE2/angiotensin (1–7) attenuates pancreatic β cell dedifferentiation in a high-fat-diet mouse model
    Xiuping Xuan et al, 2018, Metabolism CrossRef
29. Protective role of IGF-1 and GLP-1 signaling activation in neurological dysfunctions
    Sonalika Bhalla et al, 2022, Neuroscience & Biobehavioral Reviews CrossRef
30. Liraglutide Ameliorates β-Amyloid Deposits and Secondary Damage in the Ipsilateral Thalamus and Sensory Deficits After Focal Cerebral Infarction in Rats
    Hui-Li Zhu et al, 2018, Frontiers in Neuroscience CrossRef
31. Alpha-cell paracrine signaling in the regulation of beta-cell insulin secretion
    Marlena M. Holter et al, 2022, Frontiers in Endocrinology CrossRef
32. New Insights into Beta-Cell GLP-1 Receptor and cAMP Signaling
    Alejandra Tomas et al, 2020, Journal of Molecular Biology CrossRef